We monitored the mice gut microbiome, fecal short-chain fatty acids and tumor T lymphocyte infiltration in the above-mentioned treatments to explore the underlying mechanisms of the anthocyanin combo-enhanced therapeutic efficiency of PD-L1 blockade treatment. Here, CD274 is linked to neoplasm.